ALL-CAUSE MORTALITY AMONG PATIENTS TREATED WITH REPURPOSED ANTIVIRALS AND ANTIBIOTICS FOR COVID-19 IN MEXICO CITY: A REAL-WORLD OBSERVATIONAL STUDY

The aim of our study was to evaluate all-cause mortality risk in patients with laboratory-confirmed COVID-19 in Mexico City treated with repurposed antivirals and antibiotics. This real-world retrospective cohort study contemplated 395,343 patients evaluated for suspected COVID-19 between February 24 and September 14, 2020 in 688 primary-to-tertiary medical units in Mexico City.

ALL-CAUSE MORTALITY AMONG PATIENTS TREATED WITH REPURPOSED ANTIVIRALS AND ANTIBIOTICS FOR COVID-19 IN MEXICO CITY: A REAL-WORLD OBSERVATIONAL STUDY
Size: 741 KB